These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22450323)

  • 21. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
    Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
    Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
    Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
    FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
    Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
    Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1.
    Choi S; Lee YR; Park MS; Joo HK; Cho EJ; Kim HS; Kim CS; Park JB; Irani K; Jeon BH
    Biochem Biophys Res Commun; 2013 Jun; 435(3):403-7. PubMed ID: 23665318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
    Chen S; Xiong G; Wu S; Mo J
    Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain.
    Jung SB; Kim CS; Kim YR; Naqvi A; Yamamori T; Kumar S; Kumar A; Irani K
    PLoS One; 2013; 8(6):e65415. PubMed ID: 23755229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of plasma APE1/Ref-1 in lipopolysaccharide-induced endotoxemic rats: implication of serological biomarker for an endotoxemia.
    Park MS; Lee YR; Choi S; Joo HK; Cho EJ; Kim CS; Park JB; Jo EK; Jeon BH
    Biochem Biophys Res Commun; 2013 Jun; 435(4):621-6. PubMed ID: 23685156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic localization and redox cysteine residue of APE1/Ref-1 are associated with its anti-inflammatory activity in cultured endothelial cells.
    Park MS; Kim CS; Joo HK; Lee YR; Kang G; Kim SJ; Choi S; Lee SD; Park JB; Jeon BH
    Mol Cells; 2013 Nov; 36(5):439-45. PubMed ID: 24213673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
    Tell G; Damante G; Caldwell D; Kelley MR
    Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway.
    Pines A; Bivi N; Vascotto C; Romanello M; D'Ambrosio C; Scaloni A; Damante G; Morisi R; Filetti S; Ferretti E; Quadrifoglio F; Tell G
    J Cell Physiol; 2006 Oct; 209(1):44-55. PubMed ID: 16741950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress.
    Vasko MR; Guo C; Kelley MR
    DNA Repair (Amst); 2005 Mar; 4(3):367-79. PubMed ID: 15661660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
    Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
    Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APE1/Ref-1: versatility in progress.
    Jeon BH; Irani K
    Antioxid Redox Signal; 2009 Mar; 11(3):571-4. PubMed ID: 18715142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems.
    Yoo DG; Song YJ; Cho EJ; Lee SK; Park JB; Yu JH; Lim SP; Kim JM; Jeon BH
    Lung Cancer; 2008 May; 60(2):277-84. PubMed ID: 18061304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310.
    Qu J; Liu GH; Huang B; Chen C
    Nucleic Acids Res; 2007; 35(8):2522-32. PubMed ID: 17403694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death.
    Cho KJ; Kim HJ; Park SC; Kim HW; Kim GW
    Mol Cell Neurosci; 2010 Nov; 45(3):267-76. PubMed ID: 20637286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells.
    Heo JY; Jing K; Song KS; Seo KS; Park JH; Kim JS; Jung YJ; Hur GM; Jo DY; Kweon GR; Yoon WH; Lim K; Hwang BD; Jeon BH; Park JI
    Stem Cells; 2009 Jun; 27(6):1455-62. PubMed ID: 19492297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo.
    Lee YR; Park MS; Joo HK; Kim KM; Kim J; Jeon BH; Choi S
    Sci Rep; 2018 Jun; 8(1):8701. PubMed ID: 29880821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.